Can central auditory processing tests resist supramodal influences?
For the past 10 years, Cacace and McFarland have contended that current central auditory processing tests are invalid because they cannot disassociate central auditory processing disorder (CAPD) from language, attention, and other problems. Over this period of time, they have not developed a battery of tests to compare with the current procedures, so the question cannot be resolved in a proper scientific fashion. Also, we disagree with their contention and demonstrate that an experienced audiologist, under double-blind research conditions, can reliably evaluate individuals with attention-deficit/hyperactivity disorder for CAPD, whether therapeutically controlled for attention with Ritalin or taking a placebo. Further, we show how intra- and intertest comparisons, as well as a team approach, disassociate CAPD from potential contamination from supramodal factors.
Auditory Processing Service, Prairie Village, KS, USA.
Jack
J
Katz
Kim L
KL
Tillery
D000328:Adult; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002648:Child; D003072:Cognition Disorders / Q000150:complications* / Q000175:diagnosis; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007805:Language Development Disorders / Q000150:complications* / Q000175:diagnosis* / Q000503:physiopathology; D007806:Language Disorders / Q000150:complications* / Q000175:diagnosis; D008297:Male; D008774:Methylphenidate / Q000627:therapeutic use; D008875:Middle Aged; D009622:Noise / Q000009:adverse effects; D012307:Risk Factors; D013069:Speech Reception Threshold Test
D000697:Central Nervous System Stimulants; D008774:Methylphenidate